Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis

Epidemiology and Infection

Volumn 144, Issue 5, 2016, Pages 1075-1083

  Psoter, K J ^a   De Roos, A J ^b   Wakefield, J ^c   Mayer, J D ^c   Bryan, M ^d   Rosenfeld, M ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DREXEL UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; epidemiology; paediatrics; Pseudomonas; respiratory infections

Indexed keywords

RAIN;

ARTICLE; BACTERIAL STRAIN; CHILD; COHORT ANALYSIS; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; GEOGRAPHY; HUMAN; INFECTION RISK; LATITUDE; MAJOR CLINICAL STUDY; MALE; METEOROLOGICAL PHENOMENA; NONHUMAN; PSEUDOMONAS AERUGINOSA; REGISTER; RETROSPECTIVE STUDY; TEMPERATURE; COMORBIDITY; GENETICS; INFANT; MICROBIOLOGY; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PSEUDOMONAS INFECTIONS; RISK FACTOR; UNITED STATES; WEATHER;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; CYSTIC FIBROSIS; FEMALE; GEOGRAPHY; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPORTIONAL HAZARDS MODELS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; WEATHER;

EID: 84943744505     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815002411     Document Type: Article

References (43)

1. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. Journal of Clinical Epidemiology 1995; 48: 1041-1049.
2. Emerson J, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatric Pulmonology 2002; 34: 91-100.
3. Nixon GM, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. Journal of Pediatrics 2001; 138: 699-704.
4. Cystic Fibrosis Foundation. Patient registry 2012 annual report. Bethesda, MD: Cystic Fibrosis Foundation, 2013.
5. Burns JL, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. Journal of Infectious Diseases 2001; 183: 444-452.
6. Godard C, Plesiat P, Michel-Briand Y. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months. European Journal of Medicine 1993; 2: 117-120.
7. Romling U, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Journal of Infectious Diseases 1994; 170: 1616-1621.
8. Speert DP, et al. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. Journal of Clinical Microbiology 1989; 27: 2589-2593.
9. Speert DP, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. American Journal of Respiratory and Critical Care Medicine 2002; 166: 988-993.
10. Hoiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. Journal of Cystic Fibrosis 2005; 4 (Suppl. 2): 49-54.
11. Griffiths AL, et al. Effects of segregation on an epidemic Pseudomonas aeruginosa strain in a cystic fibrosis clinic. American Journal of Respiratory and Critical Care Medicine 2005; 171: 1020-1025.
12. Jones AM, et al. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. American Journal of Respiratory and Critical Care Medicine 2005; 171: 257-260.
13. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2003; 168: 918-951.
14. Kerem E, et al. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatric Infectious Disease Journal 1990; 9: 494-498.
15. Kosorok MR, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatric Pulmonology 1998; 26: 81-88.
16. Maselli JH, et al. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatric Pulmonology 2003; 35: 257-262.
17. Rosenfeld M, et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. Journal of Cystic Fibrosis 2012; 11: 446-453.
18. Arkwright PD, et al. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 2000; 55: 459-462.
19. Meyer P, Braun A, Roscher AA. Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis. Clinical Genetics 2002; 62: 325-327.
20. Baussano I, et al. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics 2006; 118: 888-895.
21. Sims EJ, et al. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment. Journal of Pediatrics 2005; 147: S42-46.
22. Collaco JM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS ONE 2011; 6: e27784.
23. Ranganathan SC, et al. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Annals of the American Thoracic Society 2013; 10: 108-114.
24. Psoter KJ, et al. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clinical Microbiology and Infection 2013; 19: E483-489.
25. Fisman DN. Seasonality of infectious diseases. Annual Review of Public Health 2007; 28: 127-143.
26. Psoter KJ, et al. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. American Journal of Epidemiology 2014; 179: 1503-1513.
27. FitzSimmons SC. The changing epidemiology of cystic fibrosis. Journal of Pediatrics 1993; 122: 1-9.
28. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. Journal of Pediatrics 2009; 155: S73-93.
29. WWAMI Rural Health Research Center. Rural-urban commuting area codes (RUCAs). (http://depts.washington.edu/uwruca/index). Accessed 16 August 2015.
30. Green DM, et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respiratory Research 2010; 11: 140.
31. McKone EF, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003; 361: 1671-1676.
32. Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Annals of Human Genetics 2003; 67: 471-485.
33. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2013.
34. Green DM, et al. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. Journal of Pediatrics 2012; 161: 290-295 e291.
35. Pittman JE, et al. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatric Pulmonology 2011; 46: 497-504.
36. Tramper-Stranders GA, et al. Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates. Clinical Microbiology and Infection 2012; 18: 567-574.
37. Kopp BT, et al. Geographic variations in cystic fibrosis: an analysis of the U.S. CF Foundation Registry. Pediatric Pulmonology 2015; 50: 754-762.
38. Fisman D. Seasonality of viral infections: mechanisms and unknowns. Clinical Microbiology and Infection 2012; 18: 946-954.
39. Lafferty KD. The ecology of climate change and infectious diseases. Ecology 2009; 90: 888-900.
40. Jones KE, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990-993.
41. McMichael AJ, Woodruff RE, Hales S. Climate change and human health: present and future risks. Lancet 2006; 367: 859-869.
42. Kidd TJ, et al. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Journal of Cystic Fibrosis 2015; 14: 361-369.
43. Rosenfeld M, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonology 1999; 28: 321-328.